from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1152/-

LFCtreatmentdescriptionclass of inhibitor

-0.549

Amikacinug/mL Amikacintranslation

-0.503

Cap5-10ug/mL Capreomycintranslation

-0.339

Rox10-50 ug/mL Roxithromycintranslation

-0.685

SM2-5 ug/mL Streptomycintranslation

0.221

Tet5-10 ug/mL Tetracyclinetranslation

-1.075

Rif0.2-5ug/mL Rifampicintranscription

-0.723

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.229

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.021

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.605

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.605

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.617

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.569

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.313

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.751

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.233

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.400

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.185

KCN5-20 ug/mL Potassium cyaniderespiration

-0.125

NaN30.2-2 mM Sodium aziderespiration

-1.646

Nigericin50 uM Nigericinrespiration

0.440

TRC10-150 ug/mL Triclosanrespiration

-0.402

TRZ10-25 ug/mL Thioridazinerespiration

-0.386

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.768

menadione6-10 ug/mL Menadionerespiration

-0.281

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.669

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.574

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.926

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.345

NRP_1Non-replicating persistence stage 1dosRassociated

-0.177

Amp0.2mg/mL AmpicillincellWall

0.125

Cephalexin20-100 ug/mL CephalexincellWall

-0.419

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.455

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.542

EMB10-20 ug/mL EthambutolcellWall

-0.108

Eta12-40 ug/mL EthionamidecellWall

0.013

INH0.2-0.4 ug/mL IsoniazidcellWall

0.050

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.265

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.075

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.142

BZA0.12 mg/mL BenzamidearomaticAmides

1.753

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.330

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.832

H2O24 mM hydrogen peroxideDNAdamaging

-0.370

Levo10 ug/mL LevofloxacinDNAdamaging

-0.486

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.057

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.572

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.456

UVUV-irradiationDNAdamaging

0.216

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.403

Antimycin12.5-50 ug/mL Antimycin A?

-0.741

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.048

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.561

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.508

PA8240.2-2 ug/mL PA-824?

1.604

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.309

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-1.522

mercaptoethanol2 mM 2-Mercaptoethanol?

0.107

methoxatin10-20 ug/mL Methoxatin?